News
News
5 May 2020
COVID-19 – Clinical research and healthcare personnel: thanks from OPIS
Since its founding, OPIS has had the opportunity to collaborate with highly qualified doctors, who…
Read more
1 May 2020
Compassionate use programs – COVID-19 authorized by AIFA
Compassionate use programs – COVID-19 authorized by AIFA
SOLNATIDE, the therapeutic molecule solnatide developed by APEPTICO…
Read more
28 April 2020
Apeptico press release
SOLNATIDE has been approved for the treatment of COVID-19 patients suffering from pulmonary oedema and…
Read more
30 March 2020
OPIS: In the front line in the fight against COVID-19
The spread of Coronavirus continues both in Italy and globally. For this reason, in order…
Read more
16 October 2019
Reshaping the future of adequate care
The paradigm of treating disease has shifted. Today, we are exploring options where personalized…
Read more
29 May 2019
The Patient Data Paradigm
The Patient Data Paradigm
Precision medicine and personalised treatment options have become a reality in…
Read more
13 October 2018
Data Managers are worth their weight in gold
The value of experienced data managers is priceless. Please click on the link to…
Read more
10 October 2017
A suited approach to rare disease trials
OPIS is currently involved in a phase II project for an ultra rare disease….
Read more
